jRCT2033240156招募中不适用
Follow-up study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass grafting
Heartseed Inc0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 80age old under（—）
- 性别
- All
入选标准
- •Subjects who participated in the HS-001-01 study and were transplanted with HS-001CS and who were able to obtain voluntary consent in writing for inclusion in this clinical trial.
排除标准
- •Patients judged by the Investigator to be ineligible shall not be included in the Clinical Trial.
结局指标
主要结局
-
Safety
次要结局
未报告次要终点
研究者
相似试验
招募中
1 期
A phase I/II study of human induced Pluripotent Stem (iPS) cell-derived cardiomyocyte spheroids in patients with severe heart failure, secondary to ischemic heart disease, undergoing coronary artery bypass graftingHeart failure with ischemic heart diseaseIschemic heart disease, Heart Failure, Coronary artery bypass grafting (CABG)JPRN-jRCT2033210163Kaneko Takehiko10
进行中（未招募）
1 期
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart FailureMedDRA version: 20.0Level: LLTClassification code: 10000803Term: Acute heart failure Class: 10007541Heart failureCTIS2024-515708-38-01niversitaetsmedizin Goettingen53
招募中
2 期
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart FailureHeart failure2024-515708-38-01Universitaetsmedizin Goettingen53
已完成
1 期
Clinical trial of human (allogeneic) induced pluripotent stem cell-derived cardiomyocyte sheet for severe cardiomyopathyIschemic cardiomyopathyJPRN-UMIN000032989Osaka University3
已完成
不适用
Human induced pluripotent stem cells to unravel the pathophysiology of peripartum cardiomyopathyPeripartum cardiomyopathypregnancy-related heart failure10019280NL-OMON40927niversitair Medisch Centrum Groningen24